Savara Added to the NASDAQ Biotechnology Index
December 20 2023 - 8:05AM
Business Wire
Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical
company focused on rare respiratory diseases, today announced that
the company was added to the NASDAQ Biotech Index (Nasdaq: NBI),
effective prior to market open on Monday, December 18, 2023.
The NASDAQ Biotechnology Index is designed to track the
performance of a set of securities listed on The Nasdaq Stock
Market® (Nasdaq®) that are classified as either biotechnology or
pharmaceutical according to the Industry Classification Benchmark
(ICB). The NASDAQ Biotechnology Index is calculated under a
modified capitalization-weighted methodology. Companies in the
NASDAQ Biotechnology Index must meet eligibility requirements,
including minimum market capitalization, average daily trading
volume, and seasoning as a public company, among other criteria.
Nasdaq selects constituents once annually in December.
For more information about the NASDAQ Biotechnology Index,
please visit https://indexes.nasdaqomx.com/Index/Overview/NBI.
About Savara
Savara is a clinical stage biopharmaceutical company focused on
rare respiratory diseases. Our lead program, molgramostim nebulizer
solution, is an inhaled granulocyte-macrophage colony-stimulating
factor (GM-CSF) in Phase 3 development for autoimmune pulmonary
alveolar proteinosis (aPAP). Molgramostim is delivered via an
investigational eFlow® Nebulizer System (PARI Pharma GmbH). Our
management team has significant experience in rare respiratory
diseases and pulmonary medicine, identifying unmet needs, and
effectively advancing product candidates to approval and
commercialization. More information can be found at
www.savarapharma.com. (X, formerly known as Twitter: @SavaraPharma,
LinkedIn: www.linkedin.com/company/savara-pharmaceuticals/).
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231220181705/en/
Savara Inc. IR & PR Anne Erickson
anne.erickson@savarapharma.com (512) 851-1366
Savara (NASDAQ:SVRA)
Historical Stock Chart
From Apr 2024 to May 2024
Savara (NASDAQ:SVRA)
Historical Stock Chart
From May 2023 to May 2024